Resources from the same session
1147 - Major determinants of delayed access to innovative medicines for metastatic melanoma: the results of Melanoma World Society and European Association of Dermato-oncology survey
Presenter: Lidija Kandolf Sekulovic
Session: Poster Discussion session - Public health policy
Resources:
Abstract
4876 - Variation in Oncology Drug Approvals in Canada, the United States and Europe
Presenter: Omar Khan
Session: Poster Discussion session - Public health policy
Resources:
Abstract
2915 - Magnitude of Clinical Benefit of Cancer Drugs Approved Based on Single-Arm Trials (SAT) by the US Food and Drug Administration (FDA)
Presenter: Consolacion Molto Valiente
Session: Poster Discussion session - Public health policy
Resources:
Abstract
4334 - Magnitude of Clinical Benefit in Trials Supporting US Food and Drug Administration (FDA) Accelerated Approval (AA) and European Medicines Agency (EMA) Conditional Marketing Authorisation (CMA) and Subsequent Trials Supporting Conversion to Full Approval
Presenter: Maria Borrell Puy
Session: Poster Discussion session - Public health policy
Resources:
Abstract
4001 - Magnitude of Clinical Benefit of Trials Supporting US Food and Drug Administration (FDA) Approval of Breakthrough and Non-breakthrough Drugs
Presenter: Consolacion Molto Valiente
Session: Poster Discussion session - Public health policy
Resources:
Abstract
4365 - Time to access to novel anticancer therapies in Slovenia in view of the ESMO-MCBS scores
Presenter: Urska Janzic
Session: Poster Discussion session - Public health policy
Resources:
Abstract
Poster Discussion session - Public health policy - Invited Discussant 1563PD, 1564PD and 1565PD
Presenter: Fredericus Eskens
Session: Poster Discussion session - Public health policy
Resources:
Slides
Webcast
4536 - Cascade BRCA Germline Mutation (BGM) Testing of women with Breast (BC) or Epithelial Ovarian Cancer( EOC) and their families with subsequent Risk Reducing Surgery(RRS): A Canadian Economics Model
Presenter: paul Hoskins
Session: Poster Discussion session - Public health policy
Resources:
Abstract
1746 - Genetic testing of BRCA mutations in breast cancer in six European countries: Barriers and opportunities
Presenter: Maia Thrift-Perry
Session: Poster Discussion session - Public health policy
Resources:
Abstract
504 - Public awareness of cancer in the Gaza-Strip: a cross-sectional study
Presenter: MohamedRaed Elshami
Session: Poster Discussion session - Public health policy
Resources:
Abstract